Literature DB >> 33147627

Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.

Franziska Hufsky1, Kevin Lamkiewicz1, Alexandre Almeida2, Abdel Aouacheria3, Cecilia Arighi4, Alex Bateman5, Jan Baumbach6, Niko Beerenwinkel7, Christian Brandt8, Marco Cacciabue9, Sara Chuguransky10, Oliver Drechsel11, Robert D Finn12, Adrian Fritz13, Stephan Fuchs11, Georges Hattab14, Anne-Christin Hauschild15, Dominik Heider16, Marie Hoffmann17, Martin Hölzer18, Stefan Hoops19, Lars Kaderali20, Ioanna Kalvari21, Max von Kleist11, Renó Kmiecinski11, Denise Kühnert22, Gorka Lasso23, Pieter Libin24, Markus List6, Hannah F Löchel15, Maria J Martin25, Roman Martin15, Julian Matschinske26, Alice C McHardy27, Pedro Mendes28, Jaina Mistry25, Vincent Navratil29, Eric P Nawrocki30, Áine Niamh O'Toole31, Nancy Ontiveros-Palacios25, Anton I Petrov25, Guillermo Rangel-Pineros32, Nicole Redaschi33, Susanne Reimering34, Knut Reinert17, Alejandro Reyes35, Lorna Richardson36, David L Robertson37, Sepideh Sadegh38, Joshua B Singer39, Kristof Theys40, Chris Upton41, Marius Welzel15, Lowri Williams42, Manja Marz18.   

Abstract

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus of the family Coronaviridae. The virus causes the infectious disease COVID-19. The biology of coronaviruses has been studied for many years. However, bioinformatics tools designed explicitly for SARS-CoV-2 have only recently been developed as a rapid reaction to the need for fast detection, understanding and treatment of COVID-19. To control the ongoing COVID-19 pandemic, it is of utmost importance to get insight into the evolution and pathogenesis of the virus. In this review, we cover bioinformatics workflows and tools for the routine detection of SARS-CoV-2 infection, the reliable analysis of sequencing data, the tracking of the COVID-19 pandemic and evaluation of containment measures, the study of coronavirus evolution, the discovery of potential drug targets and development of therapeutic strategies. For each tool, we briefly describe its use case and how it advances research specifically for SARS-CoV-2. All tools are free to use and available online, either through web applications or public code repositories. Contact:evbc@unj-jena.de.
© The Author(s) 2020. Published by Oxford University Press.

Entities:  

Keywords:  SARS-CoV-2; drug design; epidemiology; sequencing; tools; virus bioinformatics

Mesh:

Year:  2021        PMID: 33147627      PMCID: PMC7665365          DOI: 10.1093/bib/bbaa232

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  112 in total

Review 1.  Computer-based de novo design of drug-like molecules.

Authors:  Gisbert Schneider; Uli Fechner
Journal:  Nat Rev Drug Discov       Date:  2005-08       Impact factor: 84.694

2.  The hidden geometry of complex, network-driven contagion phenomena.

Authors:  Dirk Brockmann; Dirk Helbing
Journal:  Science       Date:  2013-12-13       Impact factor: 47.728

3.  Dynamic modelling of the killing mechanism of action by virus-infected yeasts.

Authors:  Sean Sheppard; Duygu Dikicioglu
Journal:  J R Soc Interface       Date:  2019-03-29       Impact factor: 4.118

4.  Modeling the effect of tat inhibitors on HIV latency.

Authors:  Luis U Aguilera; Jesús Rodríguez-González
Journal:  J Theor Biol       Date:  2019-04-17       Impact factor: 2.691

5.  A Likelihood Approach for Real-Time Calibration of Stochastic Compartmental Epidemic Models.

Authors:  Christoph Zimmer; Reza Yaesoubi; Ted Cohen
Journal:  PLoS Comput Biol       Date:  2017-01-17       Impact factor: 4.475

6.  DrugBank 5.0: a major update to the DrugBank database for 2018.

Authors:  David S Wishart; Yannick D Feunang; An C Guo; Elvis J Lo; Ana Marcu; Jason R Grant; Tanvir Sajed; Daniel Johnson; Carin Li; Zinat Sayeeda; Nazanin Assempour; Ithayavani Iynkkaran; Yifeng Liu; Adam Maciejewski; Nicola Gale; Alex Wilson; Lucy Chin; Ryan Cummings; Diana Le; Allison Pon; Craig Knox; Michael Wilson
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

7.  CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2.

Authors:  Roman Martin; Hannah F Löchel; Marius Welzel; Georges Hattab; Anne-Christin Hauschild; Dominik Heider
Journal:  iScience       Date:  2020-06-20

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals.

Authors:  Sinaye Ngcapu; Kristof Theys; Pieter Libin; Vincent C Marconi; Henry Sunpath; Thumbi Ndung'u; Michelle L Gordon
Journal:  Viruses       Date:  2017-11-08       Impact factor: 5.048

10.  The Pfam protein families database in 2019.

Authors:  Sara El-Gebali; Jaina Mistry; Alex Bateman; Sean R Eddy; Aurélien Luciani; Simon C Potter; Matloob Qureshi; Lorna J Richardson; Gustavo A Salazar; Alfredo Smart; Erik L L Sonnhammer; Layla Hirsh; Lisanna Paladin; Damiano Piovesan; Silvio C E Tosatto; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  39 in total

1.  poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing.

Authors:  Christian Brandt; Sebastian Krautwurst; Riccardo Spott; Mara Lohde; Mateusz Jundzill; Mike Marquet; Martin Hölzer
Journal:  Front Genet       Date:  2021-07-28       Impact factor: 4.599

2.  Bioinformatics-Based Approaches to Study Virus-Host Interactions During SARS-CoV-2 Infection.

Authors:  Muhammad Saad Khan; Qudsia Yousafi; Shabana Bibi; Muhammad Azhar; Awais Ihsan
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic.

Authors:  Stephen W Attwood; Sarah C Hill; David M Aanensen; Thomas R Connor; Oliver G Pybus
Journal:  Nat Rev Genet       Date:  2022-04-22       Impact factor: 59.581

4.  Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer.

Authors:  Derek W Wright; William T Harvey; Joseph Hughes; MacGregor Cox; Thomas P Peacock; Rachel Colquhoun; Ben Jackson; Richard Orton; Morten Nielsen; Nienyun Sharon Hsu; Ewan M Harrison; Thushan I de Silva; Andrew Rambaut; Sharon J Peacock; David L Robertson; Alessandro M Carabelli
Journal:  Virus Evol       Date:  2022-03-18

5.  Fast prototyping of a local fuzzy search system for decision support and retraining of hospital staff during pandemic.

Authors:  Evgeny A Bakin; Oksana V Stanevich; Daria M Danilenko; Dmitry A Lioznov; Alexander N Kulikov
Journal:  Health Inf Sci Syst       Date:  2021-05-11

6.  Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?

Authors:  Alexander B Beams; Rebecca Bateman; Frederick R Adler
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

Review 7.  Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?

Authors:  Jung-Hyun Won; Howard Lee
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

8.  Development and Evaluation of Peptidomimetic Compounds against SARS-CoV-2 Spike Protein: An in silico and in vitro Study.

Authors:  Omid Zarei; Hannah Kleine-Weber; Markus Hoffmann; Maryam Hamzeh-Mivehroud
Journal:  Mol Inform       Date:  2022-02-01       Impact factor: 4.050

9.  Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein.

Authors:  Afsaneh Sadremomtaz; Zayana M Al-Dahmani; Angel J Ruiz-Moreno; Alessandra Monti; Chao Wang; Taha Azad; John C Bell; Nunzianna Doti; Marco A Velasco-Velázquez; Debora de Jong; Jørgen de Jonge; Jolanda Smit; Alexander Dömling; Harry van Goor; Matthew R Groves
Journal:  J Med Chem       Date:  2021-07-30       Impact factor: 7.446

Review 10.  SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies.

Authors:  Ahmed M Almehdi; Ghalia Khoder; Aminah S Alchakee; Azizeh T Alsayyid; Nadin H Sarg; Sameh S M Soliman
Journal:  Infection       Date:  2021-08-02       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.